Congress, Pharmacists, Employers and Other Stakeholders Highlight PBM/Insurer Integration Harm

The House Energy and Commerce Health Subcommittee’s latest hearing, Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain, made clear that historic PBM reform is only a first step, not the finish line.  

Chairman Brett Guthrie (R-KY) highlighted how the drug supply chain has seen significant vertical integration across insurers and wholesalers that now own and operate provider groups, pharmacy services, GPOs, pharmacies and even white-label manufacturers. Rep. Debbie Dingell (D-MI) highlighted that while common sense PBM reforms were recently passed, more work needs to be done. And witnesses warned that consolidation and opacity are being used to maximize middlemen revenue at patients’ expense.  

Watch the highlight reel to see these warnings and calls for reform in lawmakers’ and witnesses’ own words. 

Learn more about policy solutions here.